Hyperlipidemia guideline adherence and association with patient gender

Journal of Women's Health

Volumn 15, Issue 9, 2006, Pages 1009-1013

  Hahn, Karissa A ^a   Strickland, Pamela A Ohman ^a,b   Hamilton, Jennifer L ^a   Scott, John G ^a   Nazareth, Tara A ^a   Crabtree, Benjamin F ^a,b,c,d  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b California State College   (United States)

^c Center for Research in Family Practice and Primary Care   (United States)

^d RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; ATTITUDE TO HEALTH; CLINICAL PRACTICE; GENERAL PRACTICE; METHODOLOGY; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PRIMARY HEALTH CARE; STANDARD; STATISTICAL MODEL; STATISTICS; UNITED STATES; WOMEN'S HEALTH;

ADULT; AGED; FAMILY PRACTICE; FEMALE; GUIDELINE ADHERENCE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPERLIPIDEMIAS; LINEAR MODELS; MALE; MIDDLE AGED; NEW JERSEY; PENNSYLVANIA; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PRIMARY HEALTH CARE; RISK ASSESSMENT; WOMEN'S HEALTH;

EID: 33847730777     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2006.15.1009     Document Type: Article

References (21)

1. Meinert CL, Gilpin AK, Unalp A, Dawson C. Gender representation in trials. Control Clin Trials 2000;21: 462.
2. American Heart Association. Heart disease and stroke statistics-2005 update. Dallas, TX: 2005.
3. Berra K. Women, coronary heart disease, and dyslipidemia: Does gender alter detection, evaluation, or therapy? J Cardiovasc Nurs 2000;14:59.
4. Schrott HG, Bittner V, Vittinghoff E, Herrington DM, Hulley S. Adherence to National Cholesterol Education Program treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/ Progestin Replacement Study (HERS). The HERS Research Group. JAMA 1997;277:1281.
5. Mosca L, Manson JE, Sutherland SE, Langer RD, Manolio T, Barrett-Connor E. Cardiovascular disease in women: A statement for healthcare professionals from the American Heart Association writing group. Circulation 1997;96:2468.
6. Tecce MA, Dasgupta I, Doherty JU. Heart disease in older women. Gender differences affect diagnosis and treatment. Geriatrics 2003;58:33.
7. Mosca L, Jones WK, King KB, Ouyang P, Redberg RF, Hill MN. Awareness, perception, and knowledge of heart disease risk and prevention among women in the United States. American Heart Association Women's Heart Disease and Stroke Campaign Task Force. Arch Fam Med 2000;9:506.
8. Kannel WB, Wilson PW. Risk factors that attenuate the female coronary disease advantage. Arch Intern Med 1995;155:57.
9. Kim C, Hofer TP, Kerr EA. Review of evidence and explanations for suboptimal screening and treatment of dyslipidemia in women. A conceptual model. J Gen Intern Med 2003;18:854.
10. Koch CG, Khandwala F, Nussmeier N, Blackstone EH. Gender profiling in coronary artery bypass grafting. J Thorac Cardiovasc Surg 2003;126:2044.
11. Keresztes PA, Merritt SL, Holm K, Penckofer S, Patel M. The coronary artery bypass experience: Gender differences. Heart Lung 2003;32:308.
12. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/ American Heart Association conference on scientific issues related to definition. Circulation 2004;109:433.
13. Hippisley-Cox J, Pringle M, Crown N, Meal A, Wynn A. Sex inequalities in ischaemic heart disease in general practice: Cross-sectional survey. BMJ 2001;322: 832.
14. Bramlet DA, King H, Young L, Witt JR, Stoukides CA, Kaul AF. Management of hypercholesterolemia: Practice patterns for primary care providers and cardiologists. Am J Cardiol 1997;80:39H.
15. Sloan KL, Sales AE, Willems JP, et al. Frequency of serum low-density lipoprotein cholesterol measurement and frequency of results < or = 100 mg/dL among patients who had coronary events (Northwest VA Network Study). Am J Cardiol 200;88:1143.
16. Di Cecco R, Patel U, Upshur RE. Is there a clinically significant gender bias in post-myocardial infarction pharmacological management in the older (>60) population of a primary care practice? BMC Fam Pract 2002;3:8.
17. Majeed A, Moser K, Maxwell R. Age, sex and practice variations in the use of statins in general practice in England and Wales. J Public Health Med 2000;22: 275.
18. Harnick DJ, Cohen JL, Schechter CB, Fuster V, Smith DA. Effects of practice setting on quality of lipid-lowering management in patients with coronary artery disease. Am J Cardiol 1998;81:1416.
19. Miller M, Byington R, Hunninghake D, Pitt B, Furberg CD. Sex bias and underutilization of lipid-lowering therapy in patients with coronary artery disease at academic medical centers in the United States and Canada. Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT) Investigators. Arch Intern Med 2000;160:343.
20. Bertakis KD, Azari R, Helms LJ, Callahan EJ, Robbins JA. Gender differences in the utilization of health care services. J Fam Pract 2000;49:147.
21. Tabenkin H, Good win MA, Zyzanski SJ, Stange KC, Medalie JH. Gender differences in time spent during direct observation of doctor-patient encounters. J Womens Health 2004;13:341.